PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	6.01T
Revenue (ttm)	2.82T
Net Income (ttm)	-481.83B
Shares Out	11.24B
EPS (ttm)	-60.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,985,600
Average Volume	50,831,465
Open	545.00
Previous Close	535.00
Day's Range	515.00 - 555.00
52-Week Range	136.00 - 700.00
Beta	1.12
RSI	45.43
Earnings Date	Apr 7, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 1,943
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2024, PT Pyridam Farma Tbk's revenue was 1.92 trillion, an increase of 173.59% compared to the previous year's 702.07 billion. Losses were -330.25 billion, 287.5% more than in 2023.